Life sciences news
-
KU Leuven kiest met Open Data-aanpak resoluut voor Open Wetenschap
Thursday January 20th 2022
Read more
-
7 (re)new(ed) strategic partnerships push flanders.bio forward into 2022
Wednesday January 19th 2022
Read more
-
Jyseleca®▼ (Filgotinib) licensed for the treatment of adult patients with moderately to severely active ulcerative colitis in Great Britain
Wednesday January 19th 2022
Read more
-
Mithra announces positive top-line results from Donesta® Phase 3 studies in menopausal women
Friday January 14th 2022
Read more
-
BioStrand secures second VLAIO research grant
Thursday January 13th 2022
Read more
-
Biotalys and Olon enter into long-term partnership for the production of protein-based biocontrols
Wednesday January 12th 2022
Read more
-
Biohaven enters exclusive license and research collaboration agreement with KU Leuven to advance first-in-class TRPM3 antagonists for the treatment of pain
Wednesday January 12th 2022
Read more
-
Oxurion provides update on clinical pipeline progress
Friday January 7th 2022
Read more
-
Become a flanders.bio member
Your news here?
-
Ardena expands capacity to satisfy Novavax COVID vaccine demand
Thursday January 6th 2022
Read more
-
Belgian research team uses AI to explain cell diversity in the fly brain
Thursday January 6th 2022
Read more
-
Univercells acquires SynHelix, entering into synthetic biology and the race to next-generation DNA synthesis
Thursday January 6th 2022
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
